INSIGHTS ON CLINICAL TRIAL PARTNERING

• The Greatest Impact Of Tax In Clinical Research

  In a recent Site Survey, Greenphire collected site perspectives on taxation in clinical trials and its impact on participants. Here, we review several real-life examples that were shared by survey participants.

• Built For Sites To Benefit All

  This one-minute video highlights the benefits of One Home for Sites. Join the movement to increase clinical trial capacity, because patients are waiting.

• What ASCO 2025 Means For The Future Of Oncology Trials

  Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.

• A Day In The Life Of A Clinical Research Site

  Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.

• Autoinjectors For Autoimmune Diseases: Benefits And Considerations

  8/7/2025

  By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.

• 5 Proven Ways To Expand Clinical Trial Site Capacity

  9/18/2025

  How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?

• Clinical Trial Logistics: Meeting Unique Participant Needs

  2/16/2024

  Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.

• The Tax Reporting Threshold Just Went from $600 to $2K — What to Know

  7/22/2025

  Explore the implications of the newly enacted "One Big Beautiful Bill" and how it will alleviate the administrative burdens faced by clinical research stakeholders and benefit low-income patients.

• PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form

  7/29/2025

  Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.